SCHEMBL6303364

SCHEMBL6303364

CCOC(=O)c1ccc2nc(C)n(Cc3ccc(-c4cccs4)cc3Cl)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.46
▸ PDE2A O00408 2/20 0.43
▸ PDE10A Q9Y233 1/20 0.43
▸ MAPT P10636 4/20 0.42
▸ TSHR P16473 2/20 0.42
▸ TP53 P04637 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6308006 0.89 PPARG (0.47) PPARGMAPTTP53
SCHEMBL6301641 0.86 PDE2A (0.51) PPARGPDE2APDE10AMAPTLMNA
SCHEMBL6173254 0.83 PPARG (0.62) PPARGPDE2APDE10AMAPTTSHR
SCHEMBL6389924 0.82 PPARG (0.46) PPARGPDE2APDE10AMAPTTSHR
SCHEMBL6308856 0.82 PPARG (0.52) PPARGPDE2APDE10AKDM4ERAB9A
SCHEMBL7652168 0.82 PPARG (0.54) PPARGPDE2APDE10AMAPTKDM4E
SCHEMBL7654594 0.82 PPARG (0.52) PPARGPDE2APDE10AMAPTLMNA
SCHEMBL6301170 0.82 PPARG (0.52) PPARGPDE2APDE10AMAPTTP53
SCHEMBL6169005 0.82 PDE2A (0.55) PPARGPDE2APDE10AMAPTTSHR
SCHEMBL6301259 0.81 PPARG (0.71) PPARGMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869950-B1 Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-03-22 — — US disclosed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 — — US disclosed
EP-1142880-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 — — EP disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP disclosed
Send feedback